Siegfried, a global Contract Development and Manufacturing Organization (CDMO) headquartered in Zofingen, Switzerland, has inaugurated a new large-scale Active Pharmaceutical Ingredient (API) manufacturing facility in Minden, Germany. The investment marks a significant milestone in the company’s ongoing expansion strategy and strengthens its position as one of the world’s leading CDMOs for small-molecule drug substances. By adding substantial production capacity and advanced manufacturing capabilities, Siegfried is further enhancing its ability to support pharmaceutical companies with complex, high-quality, and scalable API manufacturing solutions.
Additional Reactor Capacity Supports Growing Customer Demand
The newly commissioned facility adds 100 cubic meters of reactor capacity to Siegfried’s global manufacturing network, significantly expanding its ability to handle commercial-scale API production. As pharmaceutical companies increasingly seek reliable and flexible manufacturing partners, the expanded capacity will enable Siegfried to meet growing demand for complex drug substances while maintaining high standards of quality, efficiency, and regulatory compliance. The new facility also strengthens the company’s ability to support customers throughout the product lifecycle, from development and scale-up to full commercial manufacturing.
Strategic Milestone in Global Network Expansion
Marcel Imwinkelried, Chief Executive Officer of Siegfried, highlighted the strategic importance of the investment. “The inauguration of our new Minden facility is an important milestone in the continued expansion of our global manufacturing network. It strengthens our ability to support customers with complex API manufacturing at commercial scale and underlines our commitment to reliable, flexible and high-quality supply,” he said. The facility reflects Siegfried’s long-term strategy of expanding its global production footprint while strengthening supply chain resilience for pharmaceutical customers worldwide.
Advanced Technologies Drive Efficiency and Safety
The Minden facility incorporates state-of-the-art process technologies designed to optimize production performance, operational efficiency, and workplace safety. Key features include advanced automation systems, high-containment manufacturing capabilities, gravity-flow processing technology, RFID-enabled recipe management, and optimized solvent handling systems. Together, these technologies help improve process reliability, enhance product quality, and support efficient large-scale manufacturing operations while maintaining stringent safety standards.
Strengthening Large-Scale API Manufacturing Capabilities
With the addition of the new facility, Siegfried further expands its portfolio of large-scale drug substance manufacturing services. The enhanced capabilities allow the company to support increasingly complex pharmaceutical projects while providing customers with greater flexibility and scalability. As demand continues to grow for specialized and high-potency active pharmaceutical ingredients, the company is positioning itself to deliver advanced manufacturing solutions that meet evolving industry requirements.
Reinforcing Operational Excellence and Long-Term Partnerships
The Minden expansion also aligns with Siegfried’s strategic focus on operational excellence, manufacturing reliability, and customer-centric growth. By investing in advanced infrastructure and expanding its production network, the company aims to strengthen long-term partnerships with pharmaceutical innovators and generic drug manufacturers alike. The facility will play a key role in ensuring secure, high-quality supply while supporting the development and commercialization of critical medicines.
Supporting the Future of Pharmaceutical Manufacturing
The inauguration of the new Minden API facility underscores Siegfried’s commitment to expanding its global manufacturing capabilities and supporting the evolving needs of the pharmaceutical industry. As per company press release, with increased production capacity, advanced process technologies, and a strong focus on quality and efficiency, the company is well positioned to meet the growing demand for commercial-scale API manufacturing and reinforce its status as a trusted global CDMO partner.
